3 When a nuclear substance is administered to a person for therapeutic purposes, the licensee must inform the person of methods for reducing the exposure of others — including the caregiver or anyone else providing care and assistance — to radiation from the person.
- SOR/2007-208, s. 6
- SOR/2020-237, s. 3
Amended by SOR/2020-237, s. 3, in force on November 25, 2020